Preisverleihung Zell am See bei dem Kongress:

Radioactive Isotopes in Molecular Imaging & Therapy, 33^rd International Austrian Winter Symposium & 13^th Alpe Adria Nuclear Medicine, Joint Meeting, January 24^th-27^th 2018

1., 2. & 3. Platz des Allgemeinen Förderungspreises Nuklearmedizin (2017) OGNMB an die Univ.-Klinik für Nuklearmedizin Innsbruck:

Publikationen:

1.„⁶⁸Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour”. Uprimny C, Kroiss AS, Decristoforo C, Fritz J, von Guggenberg E, Kendler D, Scarpa L, di Santo G, Roig LG, Maffey-Steffan J, Horninger W, Virgolini IJ. Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):941-949.

2.“Early dynamic imaging in ⁶⁸Ga- PSMA-11 PET/CT allows discrimination of urinary bladder activity and prostate cancer lesions.” Uprimny C, Kroiss AS, Decristoforo C, Fritz J, Warwitz B, Scarpa L, Roig LG, Kendler D, von Guggenberg E, Bektic J, Horninger W, Virgolini IJ. Eur J Nucl Med Mol Imaging. 2017 May;44(5):765-775.

3.„Early PET imaging with ⁶⁸Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence.” Uprimny C, Kroiss AS, Fritz J, Decristoforo C, Kendler D, von Guggenberg E, Nilica B, Maffey-Steffan J, di Santo G, Bektic J, Horninger W, Virgolini IJ. Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1647-1655.